Navigation Links
Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO

to be forward-looking statements. There are a number of important factors that could cause the results of Kosan to differ materially from those indicated by these forward-looking statements, including, among others, risks related to the development of Kosan's Hsp90 inhibitors, including the risk that studies may not demonstrate safety and efficacy sufficient to initiate clinical trials, continue clinical development, obtain the requisite regulatory approvals or to result in a marketable product; and other risks detailed from time to time in the Company's SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2007, and other periodic filings with the SEC. Kosan does not undertake any obligation to update forward-looking statements.

Velcade(R) (bortezomib) is a registered trademark of Millennium Pharmaceuticals, Inc.

Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

CONTACT: Jane Green, VP of Corporate Communications for Kosan BiosciencesIncorporated, +1-510-731-5335, mobile, +1-415-652-4819, green@kosan.com

Web site: http://www.kosan.com/

Ticker Symbol: (NASDAQ-NMS:KOSN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:7/29/2015)... Company (NASDAQ: STAA ), a leading developer, manufacturer and ... today reported financial results for the second quarter ended July ... Net Sales of $18.7 Million Down 7% from the Prior ... from the Weakening Euro and Yen , ICL Units ... APAC Sales Down 1% Including Korea - Up 16% Excluding ...
(Date:7/29/2015)... (Vanda) (NASDAQ: VNDA ), today announced financial and ... 2015. "We are impressed with U.S. sales ... Polymeropoulos M.D., Vanda,s President and CEO, "further investments in ... set the stage for the next level of growth ... Total net product sales for the second quarter of ...
(Date:7/29/2015)... , July 29, 2015  Depomed, Inc. (NASDAQ: ... that its Board of Directors, after careful consideration ... and legal advisors, has unanimously rejected the purported ... Horizon Pharma plc (NASDAQ: HZNP ) ("Horizon") ... Depomed in an all-stock transaction (the "July 21 ...
Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 12Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 13
... ROCKVILLE, Md., April 28 Stem cell company,Neuralstem, ... the European Patent,Office has granted Neuralstem a European ... of Stem Cells from,Embryonic and Adult Central Nervous ... in several European countries including France, Germany,Ireland, Spain, ...
... Data Show Significant Improvements With ROX-828 In Migraine Pain ... And Related Symptoms For Up to 48 Hours Vs. ... PHARMA, Inc. today,announced positive top-line data from a clinical ... the treatment of migraine,and related symptoms., The placebo-controlled ...
Cached Medicine Technology:Neuralstem Announces Issuance of Core Technology Patent in Europe 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 3
(Date:7/29/2015)... , ... July 29, 2015 , ... Conventional theories used ... trade goods and services may be able to unlock mysteries about the behavior of ... University , Boston University, and Columbia University. , The findings, published July 29 in ...
(Date:7/29/2015)... ... , ... Abt Associates has named Selena Ramkeesoon, a strategic ... her position, Ramkeesoon will help build and expand work in communications, and the ... a decade at ICF International, most recently as a vice president. During her ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today the ... Shot: Expanding Prevention through Vaccination in Older Adults, that provides a comprehensive overview ... how industry, government, and health care experts can improve patient compliance. , Although ...
(Date:7/29/2015)... ... 29, 2015 , ... Angelo’s FabriClean, an area rug cleaning company in South ... carpets and rugs. The company will now reverse the damage caused by water on ... overflowing overhead tank, rain leaking through an accidently left open window or a broken ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Ticket Down is ... featuring Brazil vs. USA . , The international soccer schedule of ... grown exponentially and now on September 8th, one of the world’s greatest teams, Brazil, ...
Breaking Medicine News(10 mins):Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3
... , , TORRANCE, Calif. , Feb. 3 ... and consulting firm in California , has assembled a ...  An example of that commitment to quality and support is ... TelaDoc is a national network of board-certified physicians providing cross ...
... , Patrick ... , Feb. 3 Saint Francis Hospital,s keynote speaker at ...  cigarette company founder R.J. Reynolds and president of the Foundation for a ... will be held Thursday, Feb. 18 at 1 p.m. ...
... Feb. 3 Inverness Medical Innovations, Inc. (NYSE: ... charge of their health at home through the merger of rapid ... a binding agreement with Kroll Inc., a subsidiary of Marsh and ... Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit ...
... medical centers in eight countries, and led by researchers ... in a year-long investigation to learn whether the subtle ... the heart is better than traditional SPECT nuclear imaging ... the earliest signs of coronary artery clogs. ...
... caution against giving families false hope , ... to be in a vegetative state actually show signs ... A team of British and Belgian neuroscientists conducted functional ... diagnosed as being in a vegetative or a minimally ...
... ... program, joined by the NAACP, American Diabetes Association and Greater Philadelphia Health Action, Inc ... ... their families are expected to attend the “Outreach Day” event on Thursday, February 4, ...
Cached Medicine News:Health News:Keenan Partners With TelaDoc for 24/7 Phone Access to Physician Network 2Health News:Keenan Partners With TelaDoc for 24/7 Phone Access to Physician Network 3Health News:Tobacco Heir to Speak Out Against Tobacco at Saint Francis Hospital 2Health News:Tobacco Heir to Speak Out Against Tobacco at Saint Francis Hospital 3Health News:Tobacco Heir to Speak Out Against Tobacco at Saint Francis Hospital 4Health News:Tobacco Heir to Speak Out Against Tobacco at Saint Francis Hospital 5Health News:Inverness Medical Innovations to Acquire Kroll Laboratory Specialists, Inc. 2Health News:Inverness Medical Innovations to Acquire Kroll Laboratory Specialists, Inc. 3Health News:A better sign of blood vessel narrowing and early coronary artery disease 2Health News:A better sign of blood vessel narrowing and early coronary artery disease 3Health News:A better sign of blood vessel narrowing and early coronary artery disease 4Health News:Brain Scans Suggest Some Vegetative Patients May Be Aware 2Health News:Brain Scans Suggest Some Vegetative Patients May Be Aware 3Health News:More Than 250 Philadelphia Diabetics Expected to Attend "Outreach Day" 2
Quick release, easy to close 2" webbing and buckle. Available in teal, royal, red, purple, and maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Our unique velcro design apron with elasticized back panels for additional support and comfort. Shoulder pads are a standard. Shoulder drop-away optional....
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
We have designed unique back straps to help position the apron while giving greater back support. Shoulder pads are included for additonal comfort....
Medicine Products: